These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34074348)

  • 1. Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation.
    Padmanabhan N; Kyon HK; Boot A; Lim K; Srivastava S; Chen S; Wu Z; Lee HO; Mukundan VT; Chan C; Chan YK; Xuewen O; Pitt JJ; Isa ZFA; Xing M; Lee MH; Tan ALK; Ting SHW; Luftig MA; Kappei D; Kruger WD; Bian J; Ho YS; Teh M; Rozen SG; Tan P
    Genome Biol; 2021 Jun; 22(1):167. PubMed ID: 34074348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer.
    Zhao H; Li Q; Wang J; Su X; Ng KM; Qiu T; Shan L; Ling Y; Wang L; Cai J; Ying J
    PLoS One; 2012; 7(11):e49683. PubMed ID: 23152928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
    Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
    Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG island hypermethylator phenotype in gastric carcinoma and its clinicopathological features.
    Park SY; Kook MC; Kim YW; Cho NY; Jung N; Kwon HJ; Kim TY; Kang GH
    Virchows Arch; 2010 Oct; 457(4):415-22. PubMed ID: 20737169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subtyping of gastric cancer combining genetic and epigenetic anomalies provides distinct clinicopathological features and prognostic impacts.
    Tahara T; Tahara S; Horiguchi N; Okubo M; Terada T; Yamada H; Yoshida D; Omori T; Osaki H; Maeda K; Kamano T; Funasaka K; Nagasaka M; Nakagawa Y; Shibata T; Ohmiya N
    Hum Mutat; 2019 Mar; 40(3):347-354. PubMed ID: 30575210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach.
    Loh M; Liem N; Vaithilingam A; Lim PL; Sapari NS; Elahi E; Mok ZY; Cheng CL; Yan B; Pang B; Salto-Tellez M; Yong WP; Iacopetta B; Soong R
    BMC Gastroenterol; 2014 Mar; 14():55. PubMed ID: 24674026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dissection of premalignant colorectal lesions reveals early onset of the CpG island methylator phenotype.
    Yamamoto E; Suzuki H; Yamano HO; Maruyama R; Nojima M; Kamimae S; Sawada T; Ashida M; Yoshikawa K; Kimura T; Takagi R; Harada T; Suzuki R; Sato A; Kai M; Sasaki Y; Tokino T; Sugai T; Imai K; Shinomura Y; Toyota M
    Am J Pathol; 2012 Nov; 181(5):1847-61. PubMed ID: 22995252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
    Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
    Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
    Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
    Kusano M; Toyota M; Suzuki H; Akino K; Aoki F; Fujita M; Hosokawa M; Shinomura Y; Imai K; Tokino T
    Cancer; 2006 Apr; 106(7):1467-79. PubMed ID: 16518809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae.
    Enomoto S; Maekita T; Tsukamoto T; Nakajima T; Nakazawa K; Tatematsu M; Ichinose M; Ushijima T
    Cancer Sci; 2007 Dec; 98(12):1853-61. PubMed ID: 17900260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.
    Toyota M; Ahuja N; Suzuki H; Itoh F; Ohe-Toyota M; Imai K; Baylin SB; Issa JP
    Cancer Res; 1999 Nov; 59(21):5438-42. PubMed ID: 10554013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG island methylator phenotype and Helicobacter pylori infection associated with gastric cancer.
    Liu JB; Wu XM; Cai J; Zhang JY; Zhang JL; Zhou SH; Shi MX; Qiang FL
    World J Gastroenterol; 2012 Sep; 18(36):5129-34. PubMed ID: 23049225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
    An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative DNA methylation and gene expression analysis to assess the universality of the CpG island methylator phenotype.
    Moarii M; Reyal F; Vert JP
    Hum Genomics; 2015 Oct; 9():26. PubMed ID: 26463173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
    Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
    Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.
    Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH
    Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach.
    Rau TT; Rogler A; Frischauf M; Jung A; Konturek PC; Dimmler A; Faller G; Sehnert B; El-Rifai W; Hartmann A; Voll RE; Schneider-Stock R
    Am J Pathol; 2012 Aug; 181(2):487-98. PubMed ID: 22749770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.
    Shigeyasu K; Nagasaka T; Mori Y; Yokomichi N; Kawai T; Fuji T; Kimura K; Umeda Y; Kagawa S; Goel A; Fujiwara T
    PLoS One; 2015; 10(6):e0130409. PubMed ID: 26121593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of the prognostic value of CpG island methylator phenotype in gastric cancer.
    Powell AGMT; Soul S; Christian A; Lewis WG
    Br J Surg; 2018 Jan; 105(2):e61-e68. PubMed ID: 29341152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.